Newsroom

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today positive topline results from CT388-103, a Phase II clinical trial of CT-388, an investigational dual GLP-1/GIP receptor agonist being developed for the treatment of obesity. The study found that once-weekly subcutaneous injections of CT-388 (titrated up to 24 mg) resulted in significant and clinically meaningful placebo-adjusted weight loss of 22.5% (efficacy estim...

MIDLAND, Texas--(BUSINESS WIRE)--ProPetro Holding Corp. Announces Pricing of Upsized Public Offering of Common Stock...

SHANGHAI--(BUSINESS WIRE)--Robbyant, an embodied AI company within Ant Group, today open-sourced LingBot-Depth, a high-precision spatial perception model designed to enhance robots’ depth sensing and 3D environmental understanding capabilities in complex real-world environments. In parallel, Robbyant announced a plan to form a strategic partnership with Orbbec, a leading provider of robotics and AI vision. As part of this collaboration, Orbbec will integrate LingBot-Depth into its next-generati...

ABU DHABI, United Arab Emirates--(BUSINESS WIRE)--Ohana Development and Manchester City F.C. Sign Agreement to Launch Multi-Billion-Dirham Project in Abu Dhabi...

DUBLIN--(BUSINESS WIRE)--Cirium Ascend Consultancy has been named Appraiser of the Year 2026 in the Airline Economics Aviation 100 Global Leaders Awards, the team’s 11th title in 15 years. The Consultancy is a highly respected division of Cirium, the world’s most trusted source of aviation analytics. The Appraiser of the Year award recognizes the aircraft appraisal provider that has demonstrated the greatest contribution to the industry over the past year. The fourth consecutive win reflects th...

PARIS--(BUSINESS WIRE)--Regulatory News: Advicenne (Euronext Growth Paris - FR0013296746 - ALDVI), a pharmaceutical company specializing in the development and marketing of innovative treatments for people suffering from rare kidney diseases, obtains both marketing authorization (MA) and reimbursement status for its drug Sibnayal® (fixed combination of potassium citrate and potassium bicarbonate) in the United Arab Emirates (UAE) for the treatment of distal Renal Tubular Acidosis (dRTA). This M...

PARIS--(BUSINESS WIRE)--Regulatory News: Advicenne (Euronext Growth Paris ALDVI - FR0013296746), société pharmaceutique spécialisée dans le développement et la commercialisation de traitements innovants pour les personnes souffrant de maladies rénales rares, annonce l’obtention concomitante de l’autorisation de mise sur le marché (AMM) et du remboursement de son médicament Sibnayal® (combinaison fixe de citrate et de bicarbonate de potassium) aux Emirats Arabes Unis, dans le traitement de l’Aci...

LUXEMBOURG & BRUSSELS & LIEGE, Belgium--(BUSINESS WIRE)--SamanTree Medical, a European leader in surgical imaging innovation, has secured €20 million in financing from the European Investment Bank (EIB). The operation is backed by InvestEU, the EU’s flagship program to mobilize over €372 billion in additional investment from 2021 to 2027. The financing supports the development of an advanced confocal microscopy scanner for rapid imaging of the internal microstructure of tissue samples during su...

NEW YORK--(BUSINESS WIRE)--SpotDraft secures investment from Qualcomm Ventures to expand AI-powered contract lifecycle management for enterprise legal teams....

AUSTIN, Texas--(BUSINESS WIRE)--MindWalk Holdings Corp. (NASDAQ:HYFT) (“MindWalk” or the “Company”), a Bio-Native AI therapeutic research and technology company, today announced an application of its proprietary HYFT® technology designed to identify functional adjacency - meaning different molecules can produce the same therapeutic effect even when sequence comparisons suggest they are unrelated - an emerging source of competitive, legal, and valuation risk in modern drug discovery that sequenc...